Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3<sup>+</sup>, CD8<sup>+</sup>, and Immunoscore Are Associated with a Pathological Complete Response.

Rapoport, Bernardo Leon; Nayler, Simon; Mlecnik, Bernhard; Smit, Teresa; Heyman, Liezl; Bouquet, Isabelle; Martel, Marine; Galon, Jérôme; Benn, Carol-Ann; Anderson, Ronald

Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3⁺, CD8⁺, and Immunoscore Are Associated with a Pathological Complete Response.

Rapoport, Bernardo Leon; Nayler, Simon; Mlecnik, Bernhard; Smit, Teresa; Heyman, Liezl; Bouquet, Isabelle; Martel, Marine; Galon, Jérôme; Benn, Carol-Ann; Anderson, Ronald.

Afiliação

Rapoport BL; Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Africa.
Nayler S; The Medical Oncology Centre of Rosebank, Johannesburg 2193, South Africa.
Mlecnik B; Breast Care Centre, Milpark Hospital, Johannesburg 2193, South Africa.
Smit T; Breast Care Centre, Milpark Hospital, Johannesburg 2193, South Africa.
Heyman L; Gritzman and Thatcher Inc. Laboratories, Johannesburg 2193, South Africa.
Bouquet I; Donald Gordon Medical Centre, University of the Witwatersrand, Johannesburg 2193, South Africa.
Martel M; Inovarion, 75005 Paris, France.
Galon J; The Medical Oncology Centre of Rosebank, Johannesburg 2193, South Africa.
Benn CA; Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Africa.
Anderson R; The Medical Oncology Centre of Rosebank, Johannesburg 2193, South Africa.